Alzamend Neuro, Inc. (ALZN) Q4 2024 Earnings
ALZN·Reported December 11, 2024·Before market open
Diluted EPS came in at $-3.60, beat the $-21.42 consensus by $17.82.
Diluted EPS
$-3.60beat by $17.82
Consensus: $-21.42
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Alzamend Neuro, Inc.'s Q4 2024 earnings report.
Alzamend Neuro, Inc. (ALZN) reported Q4 2024 earnings on December 11, 2024 before market open.
Alzamend Neuro, Inc. reported diluted EPS of $-3.60 for Q4 2024.
EPS beat the consensus estimate of $-21.42 by $17.82.
You can read the 10-Q periodic report (0001214659-24-020264) directly on SEC EDGAR. The filing index links above go to sec.gov.